Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment

American Surgeon

Volumn 65, Issue 7, 1999, Pages 625-631

  Le Voyer, T E ^a   Hoffman, J P ^a   Cooper, H ^a   Ross, E ^a   Sigurdson, E ^a   Eisenberg, B ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032992886     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Parker SL, Tong T, Boldern S, et al. Cancer Statistics, 1997. Cancer J Clin 1997;47:5-27.
2. Cunsolo A, Bragaglia RB, Manara G, et al. Urogenital dysfunction after abdominoperineal resection for carcinoma of the rectum. Dis Colon Rectum 1990;33:918-22.
3. Yeager ES, Van Heerden JA. Sexual dysfunction following proctocolectomy and abdominoperineal resection. Ann Surg 1980; 191:169-70.
4. Janu NC, Bokey EL, Chapuis PH, et al. Bladder dysfunction following anterior resection for carcinoma of the rectum. Dis Colon Rectum 1986;29:182-3.
5. Jessup JM, Bothe A Jr, Stone MD, et al. Preservation of sphincter function in rectal carcinoma by a multimodality treatment approach. Surg Oncol Clin North Am 1992;1:137-45.
6. Enker WE, Paty PB, Minsky BD, Cohen AM. Restorative or preservative operations in the treatment of rectal cancer. Surg Oncol Clin North Am 1992;1:57-69.
7. Saclarides TJ, Bhattacharya AK, Britton-Kuzel C, et al. Predicting lymph node metastasis in rectal cancer. Dis Colon Rectum 1994;37:52-7.
8. Brodsky JT, Richard GK, Cohen AM, et al. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 1992;69:322-6.
9. Ottery FD, Bruskewitz RC, Weese JL. Endoscopic transrectal resection of rectal tumors. Cancer 1986;57:563-6.
10. Rosenthal SA, Yeung RS, Weese JL, et al. Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy. Cancer 1992;69:335-41.
11. Coia L, Wizenberg M, Hanlon A, et al. Evaluation and treatment of patients receiving radiation for cancer of the rectum or sigmoid colon in the United States: Results of the 1988-1989 patterns of care study process survey. J Clin Oncol 1994;12:954-9.
12. Graham RA, Garnsey L, Jessup JM. Local excision of rectal carcinoma. Am J Surg 1990;160:306-12.
13. Mendenhall WM, Million RR, Bland KI, et al. Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum. Ann Surg 1985;202:215-21.
14. Jessup JM, Bothe A Jr, Stone MD, et al. Preservation of sphincter function in rectal carcinoma by a multimodality treatment approach. Surg Oncol Clin North Am 1992;1:137-45.
15. Taylor RH, Hay JH, Larsson SN. Transanal local excision of selected low rectal cancers. Am J Surg 1998;175:360-3.
16. Bleday R, Breen E, Jessup M, et al. Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum 1997;40:338-92.
17. Steele GD, Herndon JE, Burgess AM, et al. Sphincter sparing treatment for distal rectal adenocarcinoma: A phase II intergroup study. ASCO Proc 1997;16:256a.
18. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
19. Willet CG, Lewandrowski K, Donnelly S, et al. Are there patients with Stage I rectal carcinoma at risk for failure after abdominoperineal resection? Cancer 1992;69:1651-5.
20. Blumberg D, Paty PB, Picon AI, et al. Stage I rectal cancer: Identification of high risk patients. J Am Coll Surg 1998;186:574-80.
21. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyklin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;3:227-30.
22. Jessup JM, Lavin PT, Andrews CW Jr, et al. Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Dis Colon Rectum 1995;38:1257-64.